KYORIN Pharmaceutical Co., Ltd., will conduct new drug business as a core company of the Kyorin Group, while striving to leverage the collective strengths of the Group as a whole by efficiently allocating and managing management resources.
KYORIN Rimedio Co., Ltd. mainly conducts generic drug business, while Kyorin Group Factory Co., Ltd. mainly manufactures pharmaceuticals and other products.
Group Companies
Subsidiaries
KYORIN Rimedio Co., Ltd.
| Capital | 1,200 million yen (Percentage of ownership: 100%) |
|---|---|
| Head office | 287-1, Shimocho Moroe-machi Kanazawa Shi, Ishikawa, 920-0017, Japan |
| Operations | Manufacture, sales, and procurement of pharmaceuticals and other products |
| URL | http://www.kyorin-rmd.co.jp/(Open new window) |
KYORIN Pharmaceutical Group Facilities Co., Ltd.
| Capital | 350 million yen (Percentage of ownership: 100%) |
|---|---|
| Head office | 1-3-7, Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan |
| Operations | Manufacturing and testing of pharmaceuticals and other products |
| URL | https://www.kyorin-gfc.co.jp/(Open new window) |
Equity-Method Affiliate
Nippon Rika Co., Ltd.
| Capital | 411 million (Percentage of ownership: 29.9%) |
|---|---|
| Head office | 2-2 Nihonbashi Honcho 4-chome, Chuo-ku, Tokyo, 103-0023 |
| Operations | Production and sales of pharmaceuticals, reagents, intermediates, and other products |